Alice Lin Pomponio

Naveris is a biotechnology company that provides clinically validated blood tests for the early detection of cancer.

Raised $66,334,833.00 from TechU Ventures, Gurnet Point Capital, BrightEdge Fund, R-Cubed Capital Partners, Gurnet Point Capital and Sky Ventures Group.

Nusano is a physics firm that produces radioisotopes, tiny tracers doctors use to diagnose and cure cancer and other ailments.

Raised $115,000,000.00 from Section 32 and Wasatch Group.

Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.

Raised $1,351,550,000.00 from BrightEdge Fund, T. Rowe Price, ArrowMark Partners, Roche, Section 32, Sands Capital Ventures, Artis Ventures (AV), Andreessen Horowitz, ARK Investment Management and Pura Vida Investments.

Vincere Health is a smarter incentives, biofeedback and coaching platform for behavior change.

Raised $6,039,360.00 from Inception Health, Celtic House Asia Partners, Flare Capital Partners, SixThirty, Trevor Fetter, BrightEdge Fund, The Yard Ventures, Techstars, American Family Insurance Institute for Corporate and Social Impact and Trevor Fetter.

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

Raised $154,383,867.00 from Penn Medicine Co-Investment Program, Agent Capital, The Mark Foundation for Cancer Research, Cormorant Asset Management, Quan Capital, BrightEdge Fund, OUP (Osage University Partners), RA Capital Management, Logos Capital and Pfizer Venture Investments.

Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.

Raised $97,000,000.00 from M Ventures, Evotec, 120 Capital Management, NS Investment, BrightEdge Fund, Leaps by Bayer, Medical Excellence Capital, Longwood Fund, Ono Venture Investment and Novartis Venture Fund.